Diagnostic Value of Diffusion-Weighted Imaging with Background Body Signal Suppression (DWIBS) for the Pre-Therapeutic Loco-Regional Staging of Cervical Cancer: A Feasibility and Interobserver Reliability Study.
DWIBS
MRI
cervical cancer
staging
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
13 01 2023
13 01 2023
Historique:
received:
01
11
2022
revised:
30
12
2022
accepted:
10
01
2023
entrez:
20
1
2023
pubmed:
21
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
(1) Background: cervical cancer is one of the leading causes of cancer-related deaths and the fourth most common cancer among women worldwide. Magnetic resonance imaging (MRI) is the modality of choice for loco-regional staging of cervical cancer in the primary diagnostic workup beginning with at least stage IB. (2) Methods: we retrospectively analyzed 16 patients with histopathological proven cervical cancer (FIGO IB1−IVA) for the diagnostic accuracy of standard MRI and standard MRI with diffusion-weighted imaging with background body signal suppression (DWIBS) for the correct pre-therapeutic assessment of the definite FIGO category. (3) Results: In 7 out of 32 readings (22%), DWIBS improved diagnostic accuracy. With DWIBS, four (13%) additional readings were assigned the correct major (I−IV) FIGO stages pre-therapeutically. Interobserver reliability of DWIBS was weakest for parametrial infiltration (k = 0.43; CI-95% 0.00−1.00) and perfect for tumor size <2 cm, infiltration of the vaginal lower third, infiltration of adjacent organs and loco-regional nodal metastases (k = 1.000; CI-95% 1.00−1.00). (4) Conclusions: the pre-therapeutic staging of cervical cancer has a high diagnostic accuracy and interobserver reliability when using standard MRI but can be further optimized with the addition of DWIBS sequences when reporting is performed by an experienced radiologist.
Identifiants
pubmed: 36661738
pii: curroncol30010089
doi: 10.3390/curroncol30010089
pmc: PMC9857406
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1164-1173Références
J Comput Assist Tomogr. 2004 Sep-Oct;28(5):620-7
pubmed: 15480035
Best Pract Res Clin Obstet Gynaecol. 2014 Jul;28(5):741-68
pubmed: 24861248
Abdom Radiol (NY). 2019 Jul;44(7):2557-2571
pubmed: 30903231
Int J Gynecol Cancer. 2017 Oct;27(8):1722-1728
pubmed: 28617687
Ann Nucl Med. 2018 Jun;32(5):348-362
pubmed: 29667143
Eur Radiol. 2021 Oct;31(10):7802-7816
pubmed: 33852049
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Radiat Med. 2004 Jul-Aug;22(4):275-82
pubmed: 15468951
Eur Radiol. 2018 Feb;28(2):530-541
pubmed: 28726120
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36
pubmed: 30306584
BMJ. 1992 Jun 6;304(6840):1491-4
pubmed: 1611375
Tomography. 2022 Oct 09;8(5):2522-2532
pubmed: 36287809
Clin Radiol. 1998 Mar;53(3):183-92
pubmed: 9528868
Magn Reson Imaging Clin N Am. 2022 Feb;30(1):53-72
pubmed: 34802581
Gynecol Oncol. 2019 Jan;152(1):87-93
pubmed: 30389105
Obstet Gynecol. 2009 Jul;114(1):93-99
pubmed: 19546764
Eur Radiol. 2018 Apr;28(4):1701-1708
pubmed: 29143105
Gynecol Oncol. 2013 Jun;129(3):517-21
pubmed: 23528928
Gynecol Obstet Invest. 2017;82(3):209-222
pubmed: 28183074
Int J Gynecol Cancer. 2014 Sep;24(7):1292-8
pubmed: 24987919
Obstet Gynecol. 2019 Jul;134(1):49-57
pubmed: 31188324
Am J Transl Res. 2021 Jan 15;13(1):88-101
pubmed: 33527010
Gynecol Oncol. 2013 Mar;128(3):449-53
pubmed: 23022593
J Cancer Res Clin Oncol. 2022 Apr 7;:
pubmed: 35389110
Eur Radiol. 2007 Aug;17(8):2009-19
pubmed: 17219142
Radiother Oncol. 2018 Jun;127(3):404-416
pubmed: 29728273
Eur Radiol. 2013 Jul;23(7):2005-18
pubmed: 23455762
Gynecol Oncol. 2017 Dec;147(3):577-584
pubmed: 29110878
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
pubmed: 16514137
Ultrasound Obstet Gynecol. 2021 Nov;58(5):773-779
pubmed: 33915001
Eur Radiol. 2022 Sep;32(9):6444-6455
pubmed: 35332408
Diagnostics (Basel). 2022 Dec 16;12(12):
pubmed: 36553207
Oncology. 2020;98(2):91-97
pubmed: 31593942
Br J Radiol. 2022 Mar 01;95(1131):20210459
pubmed: 34111963
Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S35
pubmed: 24674558